245 related articles for article (PubMed ID: 12061944)
1. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
Turner MR; Bakker M; Sham P; Shaw CE; Leigh PN; Al-Chalabi A
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):15-21. PubMed ID: 12061944
[TBL] [Abstract][Full Text] [Related]
2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole.
Paillisse C; Lacomblez L; Dib M; Bensimon G; Garcia-Acosta S; Meininger V
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):37-44. PubMed ID: 16036424
[TBL] [Abstract][Full Text] [Related]
4. How useful are retrospective studies in evaluating therapeutic interventions?
Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):3. PubMed ID: 12061942
[No Abstract] [Full Text] [Related]
5. Prognostic categories for amyotrophic lateral sclerosis.
Scotton WJ; Scott KM; Moore DH; Almedom L; Wijesekera LC; Janssen A; Nigro C; Sakel M; Leigh PN; Shaw C; Al-Chalabi A
Amyotroph Lateral Scler; 2012 Oct; 13(6):502-8. PubMed ID: 22670880
[TBL] [Abstract][Full Text] [Related]
6. [Survival in amyotrophic lateral sclerosis].
Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
[TBL] [Abstract][Full Text] [Related]
7. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
[TBL] [Abstract][Full Text] [Related]
8. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
[TBL] [Abstract][Full Text] [Related]
9. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population.
Thijs V; Peeters E; Theys P; Matthijs G; Robberecht W
Acta Neurol Belg; 2000 Jun; 100(2):84-90. PubMed ID: 10934559
[TBL] [Abstract][Full Text] [Related]
10. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G
J Neurol Sci; 2008 May; 268(1-2):28-32. PubMed ID: 18021808
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors in amyotrophic lateral sclerosis].
Martí-Fàbregas J; Pradas J; Illa I
Neurologia; 1996 May; 11(5):174-81. PubMed ID: 8754633
[TBL] [Abstract][Full Text] [Related]
12. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
13. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic lateral sclerosis: prognostic indicators of survival.
Mandrioli J; Faglioni P; Nichelli P; Sola P
Amyotroph Lateral Scler; 2006 Dec; 7(4):211-20. PubMed ID: 17127559
[TBL] [Abstract][Full Text] [Related]
15. [Survival prediction and related risk factors of amyotrophic lateral sclerosis:analysis of 65 cases].
Qiao L; Zhang J; Fan DS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):742-5. PubMed ID: 18683681
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying drug therapies.
Brooks BR; Sanjak M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():68-75. PubMed ID: 15512878
[No Abstract] [Full Text] [Related]
18. The ALSFRSr predicts survival time in an ALS clinic population.
Kaufmann P; Levy G; Thompson JL; Delbene ML; Battista V; Gordon PH; Rowland LP; Levin B; Mitsumoto H
Neurology; 2005 Jan; 64(1):38-43. PubMed ID: 15642901
[TBL] [Abstract][Full Text] [Related]
19. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
[TBL] [Abstract][Full Text] [Related]
20. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.
Desport JC; Marin B; Funalot B; Preux PM; Couratier P
Amyotroph Lateral Scler; 2008 Oct; 9(5):273-8. PubMed ID: 18720089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
